Trial Profile
A retrospective study of gadoxetate disodium-enhanced MRI verses computed tomography after superselective conventional transcatheter arterial chemoembolization for hepatocellular carcinoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Oct 2016
Price :
$35
*
At a glance
- Drugs Gadoxetate disodium (Primary)
- Indications Liver cancer
- Focus Diagnostic use
- 13 Oct 2016 New trial record